Inventor · disambiguated record
Niels Fisker Nielsen
Also filed as: NIELSEN NIELS FISKER
13 granted patents·7 pending applications·96 citations·filing 2007–2023
90Inventor score
Files withROCHE INNOVATION CT COPENHAGEN AS8HOFFMANN LA ROCHE3BRISTOL MYERS SQUIBB CO2HANSEN JENS BO RODE2NIELSEN NIELS FISKER2
Top patents by PatentIndex Score
20 records- 0193US8580756B2Short oligomer antagonist compounds for the modulation of target mRNAHANSEN JENS BO RODE·Filed 2008·Granted Nov 12, 2013·52 cites·17 claims
- 0292US9879265B2Oligonucleotide conjugatesROCHE INNOVATION CT COPENHAGEN AS·Filed 2014·Granted Jan 30, 2018·17 cites·34 claims
- 0387US12421516B2Antisense oligomers targeting PCSK9ROCHE INNOVATION CT COPENHAGEN AS·Filed 2023·Granted Sep 23, 2025·0 cites·26 claims
- 0487US10799523B2Tau antisense oligomers and uses thereofHOFFMANN LA ROCHE·Filed 2016·Granted Oct 13, 2020·3 cites·8 claims
- 0585US8563528B2Antisense oligomers targeting PCSK9STRAARUP ELLEN MARIE·Filed 2010·Granted Oct 22, 2013·18 cites·22 claims
- 0678US11739332B2Antisense oligomers targeting PCSK9ROCHE INNOVATION CT COPENHAGEN AS·Filed 2021·Granted Aug 29, 2023·0 cites·21 claims
- 0778US10443058B2Antisense oligomers targeting PCSK9ROCHE INNOVATION CT COPENHAGEN AS·Filed 2017·Granted Oct 15, 2019·1 cites·10 claims
- 0878US10385342B2Methods of treatment using antisense oligomers and conjugates targeting PCSK9ROCHE INNOVATION CT COPENHAGEN AS·Filed 2018·Granted Aug 20, 2019·1 cites·63 claims
- 0978US10370668B2Manufacture of antisense oligomers and conjugates targeting PCSK9ROCHE INNOVATION CT COPENHAGEN AS·Filed 2018·Granted Aug 6, 2019·1 cites·45 claims
- 1075US11091764B2Antisense oligomers targeting PCSK9ROCHE INNOVATION CT COPENHAGEN AS·Filed 2019·Granted Aug 17, 2021·0 cites·50 claims
- 1174US9290758B2Potent anti APOB antisense compoundsNIELSEN NIELS FISKER·Filed 2010·Granted Mar 22, 2016·3 cites·18 claims
- 1270US2022143064A1Tau antisense oligomers and uses thereofHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 1362US11077132B2Tau antisense oligomers and uses thereofHOFFMANN LA ROCHE·Filed 2016·Granted Aug 3, 2021·0 cites·13 claims
- 1448US2011172292A1Antidote oligomersHANSEN JENS BO RODE·Filed 2009·Application pending·0 cites
- 1547US2011054011A1RNA Antagonist Compounds for the Modulation of FABP4/AP2MCCULLAGH KEITH·Filed 2008·Application pending·0 cites
- 1647US2011224280A1Pharmaceutical Composition Comprising Anti PCSK9 OligomersNIELSEN NIELS FISKER·Filed 2009·Application pending·0 cites
- 1744US2016130582A1Oligonucleotide modulators of b-cell cll/lymphoma 11a (bcl11a) and uses thereofROCHE INNOVATION CT COPENHAGEN AS·Filed 2014·Application pending·0 cites
- 1843US11761951B2Methods of selecting therapeutic moleculesBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Sep 19, 2023·0 cites·19 claims
- 1942US2010216864A1RNA Antagonist Compounds for the Modulation of PCSK9STRAARUP ELLEN MARIE·Filed 2007·Application pending·0 cites
- 2039US2018023081A1Lna oligonucleotides with alternating flanksBRISTOL MYERS SQUIBB CO·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Niels Fisker Nielsen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →